Defective Ca2+ signalling between B cells and regulatory T cells: connecting the dots in the emergence of impaired peripheral B cell tolerance in multiple sclerosis?
Defective Ca2+ signalling between B cells and regulatory T cells: connecting the dots in the emergence of impaired peripheral B cell tolerance in multiple sclerosis?
批准号:
418405309
负责人:
Professorin Dr. Brigitte Theresia Wildemann
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Units
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2021-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The present proposal intends to advance our understanding of the molecular mechanisms regulating the control of pathogenic B cells in multiple sclerosis (MS), an autoimmune-mediated demyelinating disorder of the central nervous system (CNS). Recent evidence has revealed that an impaired peripheral B cell tolerance accounts for heightened frequencies of pathogenic B cells in patients with MS. This might arise through aberrations in B cell regulation from T cell-independent processes, or through T cell-dependent processes mediated by regulatory T cells (Tregs). Tregs are functionally deficient in patients with MS as we and others have previously shown. Their loss of suppressive properties is precipitated by a contraction of naive cells and reciprocal expansion of memory phenotypes in the peripheral Treg cell compartment, which in turn, possibly arises from premature immunosenescence. At present, little is known as to whether B cells are direct targets of Tregs and how they achieve suppression of B cell effector functions such as immunoglobulin production, antigen presentation, and cytokine secretion. Furthermore, while Modulation of effector T cell responses through B cells is known to occur, the question whether B cells also impact Treg activity has not been addressed. Since any impairment in the bi-directional interaction between the two cell subsets might have harmful consequences on developing autoimmune responses in patients with MS, we aim to analyze the cross-talk between B cells and Tregs in more detail. We intend to employ live Imaging of single cells to measure the capacity of Tregs to modulate Ca2+ signaling in surrounding B cells of various phenotypes, which is a key mechanism utilized by Tregs to confer suppression in conventional T cells (Tcons) as we have previously shown. The imaging experiments will be complemented by assessing the correlation between Ca2+ oscillation patterns and Ca2+-driven downstream events of B cell activation. Complementary experiments aim to clarify whether B cells directly influence the functional capacity of Tregs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
基于“过咸伤肾”理论探讨补肾开心散调控ENaC泛素化-Ca2+轴改善MCI神经元钙超载的机制
-
批准号:JCZRLH202600550
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
一种Ca2+响应性天然抗癌肽的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张鹏
-
依托单位:
电针抑制线粒体膜MICU/MCU通道介导Ca2+依赖的mtROS释放抑制神经元铁死亡治疗缺血性脑卒中的机制研究
-
批准号:2026JJ80608
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周璐
-
依托单位:
毛蕊异黄酮通过KCMF1 介导KCNN4 泛素化调控 Ca2+/VDR 通路抑制肝纤维化的机制研究
-
批准号:ZCLQN26H3102
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:祝馨平
-
依托单位:
褪黑素经由ROS/CaMKII/RyR2轴调控心肌Ca2+稳态改善睡眠剥夺大鼠房颤易感性的机制研究
-
批准号:JCZRLH202600126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
缢蛏Gq-opsins介导光谱差异驱动Ca2+信号转导的机制研究
-
批准号:QN25C190011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:孔菲
-
依托单位:
基于IP3R/Ca2+信号轴研究肌醇干预中华鳖肠道紧密连接功能障碍的机制
-
批准号:QN25C190025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:罗嘉翔
-
依托单位:
木犀草素调控GPR40/PLC/IP3R引起胞浆Ca2+浓度升高促进胰岛素分泌作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
Ca2+促进亲脂弱酸性药物载入脂质体磷
脂双层膜的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:索绪斌
-
依托单位:
乳酸通过激活Ca2+/NFAT1轴驱动Treg细胞上调CCR8促进肿瘤进展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡超
-
依托单位: